Loading...
OTCM
PPTMF
Market cap576kUSD
, Last price  
USD
Name

Pharmacolog I Uppsala AB (publ)

Chart & Performance

D1W1MN
OTCM:PPTMF chart
P/E
P/S
EPS
0.43
Div Yield, %
Shrs. gr., 5y
-19.89%
Rev. gr., 5y
50.26%
Revenues
15m
+109.83%
212,000682,0001,015,984242,20413,966798,3271,035,0002,182,0001,901,0008,816,00010,114,0009,936,0006,939,09414,560,000
Net income
2m
P
-718,000-1,512,000-1,057,000-7,469,000-11,237,000-9,944,000-12,385,000-16,729,000-14,588,000-13,712,000-19,164,000-18,277,000-2,473,1442,452,000
CFO
-5m
L-22.26%
-230,000-867,000-1,108,903-5,862,992-9,156,329-9,342,205-11,032,738-13,859,218-10,209,966-15,335,911-19,188,152-16,412,000-7,027,346-5,463,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 2007 and based in Uppsala, Sweden, Pharmacolog i Uppsala AB (publ) creates innovative systems and solutions to improve the safety and precision of intravenous drug handling. Their offerings include DrugLog, a system engineered to minimize errors during medication administration. They also provide WasteLog, a specialized device for analyzing and managing discarded or returned injectable controlled substances. Additionally, PrepLog, an advanced platform leveraging DrugLog technology, seamlessly connects with prescription and medication management software to verify drug preparations.
IPO date
Aug 06, 2015
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT